Open AccessWhat now on the CANVAS of diabetes medications with cardiovascular protection? Could metformin, pioglitazone, SGLT2 inhibitors and liraglutide complement each other to save lives?
Author(s) -
Robert E. Ryder,
Ralph A. DeFronzo
Publication year - 2017
Publication title -
the british journal of diabetes
Language(s) - English
Resource type - Journals
eISSN - 2397-6241
pISSN - 2397-6233
DOI - 10.15277/bjd.2017.036
Subject(s) - liraglutide , pioglitazone , metformin , medicine , diabetes mellitus , complement (music) , pharmacology , endocrinology , type 2 diabetes , chemistry , biochemistry , complementation , phenotype , gene